Acorah Software Products - Accounts Production 16.2.850 false true false true No description of principal activity 24 January 2024 31 January 2025 31 January 2025 15440144 Dr S Zaro iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15440144 2024-01-23 15440144 2025-01-31 15440144 2024-01-24 2025-01-31 15440144 frs-core:CurrentFinancialInstruments 2025-01-31 15440144 frs-bus:PrivateLimitedCompanyLtd 2024-01-24 2025-01-31 15440144 frs-bus:FilletedAccounts 2024-01-24 2025-01-31 15440144 frs-bus:Micro-entities 2024-01-24 2025-01-31 15440144 frs-bus:AuditExempt-NoAccountantsReport 2024-01-24 2025-01-31 15440144 frs-bus:Director1 2024-01-24 2025-01-31
Registered number: 15440144
Ibishaq Limited
Unaudited Financial Statements
For the Period 24 January 2024 to 31 January 2025
Balance Sheet
Registered number: 15440144
31 January 2025
£
Current assets 42,613
Creditors: Amounts Falling Due Within One Year (13,234 )
NET CURRENT ASSETS 29,379
TOTAL ASSETS LESS CURRENT LIABILITIES 29,379
Accruals and deferred income (1,200 )
NET ASSETS 28,179
CAPITAL AND RESERVES 28,179

Notes

1. General Information
Ibishaq Limited is a private company, limited by shares, incorporated in England & Wales, registered number 15440144 . The registered office is 89a Humberston Avenue Humberston, Grimsby, DN36 4ST.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved by the board of directors on 31 March 2025 and were signed on its behalf by:
Dr S Zaro
Director
31 March 2025